HC Wainwright & Co. Reiterates Buy on Acelyrin, Maintains $28 Price Target

Moomoo 24/7 ·  Apr 1 06:47

HC Wainwright & Co. analyst Emily Bodnar reiterates Acelyrin (NASDAQ:SLRN) with a Buy and maintains $28 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment